ArticlemAbs
Durable blockade of PD-1 signaling links preclinical efficacy of sintilimab to its clinical benefit.
Jie Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
87 papers cite itlatest 60 shown
pooled ittrialcites it
ArticlemAbs
Jie Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.